Navigation Links
Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
Date:7/30/2009

irman.

Tajib A. Mirzabekov, Ph.D., President and CEO of MSM commented: "This is a very exciting transaction for MSM. We are working with a great partner, on a very exciting and valuable target and we have the chance to launch what may be the first novel biologic in Russia through our Russian subsidiary, Meprotek. It provides a substantial validation for our technology and our team to work with a company of Debiopharm's caliber. There is a great need in targeting of GPCRs with functionally active, high quality and potent human monoclonal antibodies."

About Debiopharm Group

Debiopharm Group is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. It develops its products for global registration and maximum commercial potential. Once registered, the products are out-licensed to pharmaceutical partners for sales and marketing.

Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.

Founded in 1979 and headquartered in Lausanne, Switzerland, Debiopharm has developed four products with global combined sales in excess of $2.6 billion in 2008.

For more information on Debiopharm Group, please visit: http://www.debiopharm.com.

About MSM Protein Technologies

MSM is a closely held drug discovery company based in Boston, MA. MSM is the leader in the discovery of antibodies targeting multispanning membrane proteins. The company applies its proprietary SIMPL (TM) platform and magnetic proteoliposome particles (MPLs) to display multispanners such as GPCRs in highly concentrated and purified form while retaining their native conformation and orientation th
'/>"/>

SOURCE Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
2. Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions
3. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
4. Japanese Cancer Association and Debiopharm Honour Japanese Research
5. Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
6. Debiopharm and EPFL Establish an Oncology Chair
7. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
8. Debiopharm Receives cGMP Certification for Quality Control of its Drug Products
9. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
10. SAFC Biosciences(R) Defines Hydrolysate Components That Enhance Chinese Hamster Ovary (CHO) Cell Line Protein Production
11. PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 The ... and Transplant Association) is the biggest congress in ... therapy. Nearly 10,000 participants are in Istanbul ... latest research findings. New pioneering studies have been presented: ... FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...
(Date:5/21/2013)... Canada (PRWEB) May 21, 2013 ... is a strong push within the industry to ... and Manufacturing Organizations and pharma companies often means ... frames. , Microtablets, developed in collaboration with Sensidose ... effective outsourcing can bring products to market sooner. ...
(Date:5/21/2013)...  Personal Genome Diagnostics Inc. (PGDx), today announced ... expertise in genomic analysis of defined cancer subtypes ... Blueprint Medicines.  PGDx is an innovator in conducting ... tumors, and Blueprint Medicines is an expert in ... defined patient population. "This collaboration brings ...
(Date:5/21/2013)... Vital Imaging ™ has teamed up with ... for a joint study which aims to compare the ... with that of a supine Dynawell MRI scanner. Vital ... healthcare by combining cutting edge technology with progressive research ... for evaluating pathological changes in the spine, vertebral bodies, ...
Breaking Biology Technology:ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3
... FORTUNE,S 100 Fastest-Growing Companies, List -- SHANGHAI, Aug. 26 /PRNewswire-Asia-FirstCall/ -- ... ... ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
... Hikma - Half Year Results Interviews With CEO and CFO -- LONDON, August 26, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... bag of potato chips or pop in a DVD, you,re probably ... soap. Sputter deposition is an industrial process used since the ... various backings, like the metallic coating on potato chip bags, the ... Mostly, the process works very well. In a vacuum chamber filled ...
Cached Biology Technology:China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List 2China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List 3China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List 4China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List 5China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List 6China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List 7Hikma - Half Year Results Interviews With CEO and CFO 2Hikma - Half Year Results Interviews With CEO and CFO 3Hikma - Half Year Results Interviews With CEO and CFO 4Hikma - Half Year Results Interviews With CEO and CFO 5Trouble with sputter? Blame giant nanoparticles 2Trouble with sputter? Blame giant nanoparticles 3
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... USC have found that a class of pharmaceuticals can ... , The drugs, known as "TSPO ligands," are currently ... at the effects of TSPO ligand in young adult ... in aged mice when pathology was quite severe," said ... of Gerontology. "TSPO ligand reduced measures of pathology and ...
(Date:5/21/2013)... all types become most deadly when they metastasize and ... this stage, it becomes very difficult for doctors to ... Now, researchers at the University of Missouri have found ... tumor cells wherever they may be in the body. ... MU College of Veterinary Medicine, says being able to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2
... This release is available in French ... Scientists from the Universit de Montral and its affiliated ... the National Sciences and Engineering Research Council of Canada ... institutions to launch training and mentorship programs for promising ...
... Almost two million years ago, early humans began eating food ... could have played an important role in the evolution of ... new research. In what is the first evidence of ... international team of researchers has discovered early stone tools and ...
... the atomic and molecular levels nanoscale have ... level where everything happens. Alexandra Navrotsky, Distinguished ... of its Nanomaterials in the Environment, Agriculture, and Technology ... throughout her career. She presented her findings today in ...
Cached Biology News:NSERC awards $3 million for UdeM and Polytechnique training programs 2Nanoparticle scientist speaks on new discoveries at Goldschmidt Conference 2
... generation of microarrays to detect alternative splicing. ... rapidly elucidate alternatively spliced events in gene ... discovery. The service combines ExonHits proprietary splice ... analysis with Agilents robust microarray platform. The ...
... CE 4100 high pressure pump with ... with software drive compensation, reducing pulsing to ... selectable in 0.001mL steps. , The pump ... bio-compatible., Pumps may be programmed from their ...
... III variable angle system, 220-240 V, is used ... Mb DNA fragments by pulsed field gel electrophoresis ... module, variable-speed pump, 14 x 13 cm casting ... 1.5 mm thick comb, screened cap, disposable plug ...
... PVDF membrane and filter paper sandwiches are ... and two sheets of thick filter paper ... and filter paper sandwich. These 7 x ... capacity immunoblotting fit Ready Gel-sized gels and ...
Biology Products: